Artwork

Content provided by Omnicell. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Omnicell or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Reverse Your Reliance on 503Bs for Compounded Sterile Products

33:03
 
Share
 

Manage episode 322992879 series 3266773
Content provided by Omnicell. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Omnicell or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Health systems are continuously being challenged to ensure IV preparations are prepared safely and accurately while complying with increasingly complex regulations. As a result, many rely on 503B outsourcing pharmacies to provide the vast majority of their pre-mixed compounded sterile products. But as product shortages and pricing fluctuations in the supply chain become more acute, rather than provide relief, 503Bs actually can put more pressure on pharmacy staffs and budget.

Joining host Ken Perez to discuss are pharmacy leaders who met those challenges by going against the trend – by insourcing their sterile compounding, with a twist.

  • Joseph J. DiCubellis, RPh, MPH, Senior Director of Pharmacy Services for the University of Maryland Medical System and Senior Director of Pharmacy, University of Maryland Medical Center
  • Yevgeniya Kogan-Hardesty, PharmD, BCSCP, Sterile Compounding, Pharmacy Manager, University of Maryland Medical Center

  continue reading

23 episodes

Artwork
iconShare
 
Manage episode 322992879 series 3266773
Content provided by Omnicell. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Omnicell or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Health systems are continuously being challenged to ensure IV preparations are prepared safely and accurately while complying with increasingly complex regulations. As a result, many rely on 503B outsourcing pharmacies to provide the vast majority of their pre-mixed compounded sterile products. But as product shortages and pricing fluctuations in the supply chain become more acute, rather than provide relief, 503Bs actually can put more pressure on pharmacy staffs and budget.

Joining host Ken Perez to discuss are pharmacy leaders who met those challenges by going against the trend – by insourcing their sterile compounding, with a twist.

  • Joseph J. DiCubellis, RPh, MPH, Senior Director of Pharmacy Services for the University of Maryland Medical System and Senior Director of Pharmacy, University of Maryland Medical Center
  • Yevgeniya Kogan-Hardesty, PharmD, BCSCP, Sterile Compounding, Pharmacy Manager, University of Maryland Medical Center

  continue reading

23 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide